Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,742 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07136675Enrolling by invitation
Healthy Heart & Blood Markers in Chinese Adults
This study aims to create a reference library of healthy hearts and blood markers for Chinese adults. If you qualify, you will help doctors better understand what's normal for people like you.
Beijing, Beijing MunicipalityAges 20–80 - NCT07132255Enrolling by invitation
Study of remote robot-assisted heart stent placement
This trial tests whether a doctor can use a robot to place a heart stent while being in a different location. It is designed for people who need a stent to open a blocked heart artery.
Jimsar, Xinjiang Uygur Autonomous RegionAges 18–80 - NCT07130968Enrolling by invitation
Heart and lung function study with exercise test and five-year follow-up
This study looks at how your heart and lungs work during exercise by using a special test called a cardiopulmonary exercise test (CPET). Researchers will follow you for up to five years to see how your health changes. It may help you understand your heart condition better and get more personalized care.
Guangzhou, GuangdongAges 18–80 - NCT07129005Enrolling by invitation
MRI-based tool to tell uterine sarcoma from fibroids
This trial uses MRI scans to see if a computer can tell the difference between uterine sarcoma (a rare cancer) and fibroids (non-cancerous growths). If you've already been diagnosed with one of these and had an MRI before surgery, you may be able to help.
Wuhan, HubeiAges 18 years+ - NCT07128771Enrolling by invitation
Heart effects of gender-affirming hormone therapy
This study looks at how gender-affirming hormone therapy affects the heart and blood vessels. It aims to understand any changes in heart health for transgender individuals starting or continuing this treatment.
Oslo, OsloAges 16 years+ - NCT07126197Enrolling by invitation
Lymphovenous bypass for diabetic nerve pain
This study tests if a surgery called lymphovenous bypass can reduce nerve pain caused by diabetes. It may help people with diabetic peripheral neuropathy, even if they have foot ulcers.
TaipeiAges 20–80 - NCT07123922Enrolling by invitation
Silymarin for COPD: A Study on Breathing and Quality of Life
This study tests whether adding silymarin (a herbal supplement from milk thistle) to your regular COPD treatment can improve your lung function, reduce stress in your body, and help you feel better day-to-day.
DhakaAges 40–80 - NCT07107789Enrolling by invitation
Can animated videos help kids with type 1 diabetes?
This study tests whether watching short education videos with animations can help children with type 1 diabetes better manage their blood sugar, take care of themselves, and feel more positive about their condition. It's for kids aged 11 to 18 who use an insulin pen.
Erzurum, PalandökenAges 11–18 - NCT07104136Enrolling by invitation
Training doctors to improve COPD treatment adherence
This trial trains primary care doctors to help their COPD patients stick with treatments. It tests whether a new coaching approach can improve medication use and health outcomes.
Tel AvivAges 18 years+ - NCT07102849Enrolling by invitation
Studying bone marrow failure with biospecimens and data
This study analyzes blood, bone marrow, and medical information from people with bone marrow failure syndromes (BMFS) and healthy volunteers to better understand these conditions and find new ways to help patients.
Bethesda, MarylandAges 2–120 - NCT07102121Enrolling by invitation
Comparing tooth sensitivity after cementing crowns with two dental materials
This study tests whether one type of dental cement causes less tooth sensitivity than another after placing a crown. The results could help your dentist choose the material that feels better for you.
Mingora, Khyber PakhtunkhwaAges 15–60 - NCT07088809Enrolling by invitation
Nanoparticles with Platelet-Rich Fibrin for Gum Recession
This trial tests a new material to treat gum recession—tiny particles mixed with your own blood components (platelet-rich fibrin) placed as a membrane. The goal is to see if it helps cover exposed roots and improve gum health.
Tanta, Gharbia GovernorateAges 20–45 - NCT07081841Enrolling by invitation
Long-term follow-up for AB-1005 study participants
This trial is for people with Parkinson's disease or multiple system atrophy (parkinsonian type) who took part in an earlier AB-1005 study. It will continue to monitor your health over time to learn more about the treatment's long-term effects.
San Francisco, CaliforniaAges Any age - NCT07077811Enrolling by invitation
Pulsed field ablation for heart failure with preserved pumping strength
This trial tests a new procedure called pulsed field ablation for people who have both persistent atrial fibrillation and a type of heart failure (HFpEF). It aims to see if this ablation safely helps control the heart rhythm.
Nantong, JiangsuAges 18–80 - NCT07074093Enrolling by invitation
Smartphone app to help COPD patients with air pollution
This study tests whether a smartphone app can help people with COPD breathe better by giving them tips to avoid air pollution. If you live in Salamanca and can use a smartphone, this app might help you manage your condition.
Salamanca, SalamancaAges 18 years+ - NCT07060235Enrolling by invitation
Mobile app for disc herniation recovery
This trial tests a mobile app that guides you through exercises for disc herniation. The app is designed to help strengthen the muscles that support your spine and may reduce pain.
AnkaraAges 20–55 - NCT07055971Enrolling by invitation
Pain education and brain training for fibromyalgia
This trial tests whether a program that teaches you about pain and helps your brain control pain better can improve fibromyalgia symptoms. It also looks at how emotions play a role.
Granada, AndalusiaAges 18 years+ - NCT07050810Enrolling by invitationEarly Phase 1
Bath system for chronic skin conditions
This study tests a special bath system (Thera-Clean Microbubbles) to see if it helps people with certain skin conditions like psoriasis, eczema, epidermolysis bullosa, or ichthyosis. It's designed for people whose skin is stable and who can follow a home bathing routine.
Chicago, IllinoisAges 2 years+ - NCT07046234Enrolling by invitation
Lung ultrasound for people with shortness of breath
This trial uses a portable ultrasound at the bedside (called point-of-care lung ultrasound) to quickly examine the lungs of people who are having trouble breathing. The goal is to see how well this test works for finding lung problems in the hospital or clinic.
New Haven, ConnecticutAges 22 years+ - NCT07045493Enrolling by invitationPhase 2
Combination therapy for soil-transmitted worms in children aged 2-5
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
DhakaAges 2–5 - NCT07045233Enrolling by invitation
Using a brain protection device during TAVR to prevent stroke
This study tests if a special device placed during transcatheter aortic valve replacement (TAVR) can help prevent stroke. It is for adults with severe aortic stenosis who are already scheduled for TAVR.
BeijingAges 18 years+ - NCT07038447Enrolling by invitationPhase 1
KITE-363 for refractory autoimmune diseases
This trial tests a new cell therapy called KITE-363 for people with certain autoimmune diseases (lupus, lupus nephritis, systemic sclerosis, or idiopathic inflammatory myopathy) that haven't improved with standard treatments. It aims to see if this therapy can help control the disease.
Duarte, CaliforniaAges 18 years+ - NCT07038213Enrolling by invitation
Study of kidney protection in type 2 diabetes
This study looks at how genes may affect kidney disease in people with type 2 diabetes. It tests treatments to protect the kidneys. If you are of Kazakh ethnicity and have type 2 diabetes, you may be able to join.
AstanaAges 18–65 - NCT07035132Enrolling by invitation
Special supplement for patients with cancer at risk of malnutrition
This trial tests a special liquid supplement for patients with head, neck, lung, rectal, or esophageal cancer who are having radiation and are malnourished or at risk. The supplement is designed to be easier to digest if you have stomach or gut issues.
AlicanteAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,742 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.